Vilanterol Trifenatate

CHEMBL1084172 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

774.8 g/mol

LogP

—

Phase

4

Vilanterol trifenatate is the triphenylacetate salt of vilanterol, an ultra-long-acting beta-2 agonist (LABA) used for maintenance therapy of asthma and COPD in combination with other agents. The trifenatate salt form is used in the inhaled powder formulations marketed for once-daily maintenance bronchodilation. Like the free base, it provides >24 hours of beta-2 receptor-mediated bronchial smooth muscle relaxation.

分子量

774.8000 g/mol

TPSA

128.00 Å²

治療領域

Asthma Chronic Obstructive Pulmonary Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O

InChI

InChI=1S/C24H33Cl2NO5.C20H16O2/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28;21-19(22)20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h5-9,14,24,27-30H,1-4,10-13,15-17H2;1-15H,(H,21,22)/t24-;/m0./s1

Molecular Formula

C44H49Cl2NO7

HBD / HBA

5 / 8

回転可能結合数

20

重原子数

54

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Vilanterol trifenatate is the triphenylacetate salt of vilanterol, an ultra-long-acting beta-2 agonist (LABA) used for maintenance therapy of asthma and COPD in combination with other agents. The trifenatate salt form is used in the inhaled powder formulations marketed for once-daily maintenance bronchodilation. Like the free base, it provides >24 hours of beta-2 receptor-mediated bronchial smooth muscle relaxation.

Yes, Vilanterol Trifenatate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1084172. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 44482554. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Vilanterol Trifenatate PillFYIで

構造

クイックデータ

分子式: C44H49Cl2NO7
同義語: 4

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.